Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: Results from the SPIRE randomized trials of bococizumab
| Image |  |
|---|---|
| Description | scientific article published on 3 April 2018 |
| Author/s |
author: Studies of PCSK9 Inhibition and the Reduction of vascular Events (SPIRE) Investigators Deniz Demirci John J. P. Kastelein Carla Yunis Paul Ridker Lynda M Rose Jean-Claude Tardif |
| Publication date | April 3, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |